Prehospital evaluation and economic analysis of different coronary syndrome treatment strategies - PREDICT - Rationale, Development and Implementation by Morrison, Laurie J et al.
STUDY PROTOCOL Open Access
Prehospital evaluation and economic analysis of
different coronary syndrome treatment strategies -
PREDICT - Rationale, Development and
Implementation
Laurie J Morrison
1,2*, Valeria E Rac
1,3, James M Bowen
4, Brian Schwartz
5, Tyrone Perreira
1, Welson Ryan
1,
Cathy Zahn
1, Rishab Chadha
1, Alan Craig
1,6, Daria O’Reilly
4 and Ron Goeree
4
Abstract
Background: A standard of prehospital care for patients presenting with ST-segment elevation myocardial
infarction (STEMI) includes prehospital 12-lead and advance Emergency Department notification or prehospital
bypass to percutaneous coronary intervention centres. Implementation of either care strategies is variable across
communities and neither may exist in some communities. The main objective is to compare prehospital care
strategies for time to treatment and survival outcomes as well as cost effectiveness.
Methods/Design: PREDICT is a multicentre, prospective population-based cohort study of all chest pain patients
18 years or older presenting within 30 mins to 6 hours of symptom onset and treated with nitroglycerin,
transported by paramedics in a number of different urban and rural regions in Ontario. The primary objective of
this study is to compare the proportion of study subjects who receive reperfusion within the target door-to-
reperfusion times in subjects obtained after four prehospital strategies: 12-lead ECG and advance emergency
department (ED) notification or 3-lead ECG monitoring and alert to dispatch prior to hospital arrival; either with or
without the opportunity to bypass to a PCI centre.
Discussion: We anticipate four challenges to successful study implementation and have developed strategies for
each: 1) diversity in the interpretation of the ethical and privacy issues across 47 research ethics boards/
commiittees covering 71 hospitals, 2) remote oversight of data guardian abstraction, 3) timeliness of
implementation, and 4) potential interference in the study by concurrent technological advances. Research ethics
approvals from academic centres were obtained initially and submitted to non academic centre applications. Data
guardians were trained by a single investigator and data entry is informed by a detailed data dictionary including
variable definitions and abstraction instrucations and subjected to error and logic checks. Quality oversight
provided by a single investigator. The window of the trial in each community has been confirmed with the
basehospital medical director to correspond to the planned technological advances of the system of care. We
hope this comparative analysis across treatment strategies for clinical outcomes and cost will provide sufficient
evidence to implement the superior strategy across all communities and improve outcomes for all STEMI patients.
Trial registration: ClinicalTrials.gov: NCT00747656
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Cardiovascular disease accounts for more deaths than
any other disease and ischemic heart diseases, such as
acute myocardial infarction (AMI), account for a large
proportion of these deaths [1-3]. Timely recognition and
reperfusion are life saving interventions [3-7]. Rando-
mized controlled trials have demonstrated the superiority
of prehospital fibrinolysis [8-11]; whereas other interven-
tions such as 12-lead [12-15] and bypass to interventional
hospitals [6,16-23] have not been subjected to the same
rigorous analysis. Based on associations with improved
time to treatment, 12-lead ECG and bypass to an inter-
ventional hospital has been implemented in many com-
munities which makes it difficult to conduct a controlled
trial. In contrast, many rural and urban communities
with small volumes may not have implemented any one
of these interventions, as such the standard of care for
patients presenting with ST-segment elevation myocar-
dial infarction (STEMI) varies between communities [24].
In 2004, the expert panel of Cardiac Care Network of
Ontario report recommended that urgent angioplasty
should be adopted as the standard of care[24]. Concur-
rent with this report the Ontario Health Technology
Advisory Committee (OHTAC), upon their review of the
literature regarding primary angioplasty for the treatment
of STEMI, recommended that “every effort should be
made to decrease the access time for patients with AMI
from onset to symptoms to administration of fibrinolysis
or primary angioplasty”[25,26]. This study is being con-
ducted to evaluate different implementation strategies in
place currently that could reduce symptom to interven-
tion time in Ontario[25]. The objective of this paper is to
describe the design of a study to compare these strategies
against time to treatment and survival outcomes as well
as cost effectiveness. We hope that this prospective
cohort trial will promote the adoption of the optimal
implementation strategy into the healthcare system and
may provide the information required to directly change
health policy and funding for systematic multidisciplinary
care involving local EMS systems. We anticipate that the
identification and implementation of the best care strat-
egy may provide consistent and optimal care of patients
presenting with STEMI across all communities in
Ontario,
Methods/Design
Study Design
PREDICT is a prospective, population-based cohort study
of four patient care strategies provided by regional EMS
services to patients with chest pain and suspected ischemia.
1. 3-lead PHECG and transported to the nearest
receiving ED who were not eligible for bypass based
on transport time.
2. 3-lead PHECG and transported to the nearest
receiving ED who were eligible for bypass based on
transport time, if 12 lead PHECG was possible.
3. 12-lead PHECG and prehospital notification trans-
ported to the nearest receiving ED who were not eli-
gible for bypass to a PCI center based on transport
time.
4. 12-lead PHECG with prehospital notification and
eligible for bypassing the nearest receiving ED with
transport to a PCI center.
Bypass eligibility was based on transport distance of
patients from their pick-up location to PCI center and
the cut-off point was 60 kilometres.
Inclusion and Exclusion Criteria
Inclusion criteria
○ Patients who call 911, and are:
○ Suspected by the paramedics to have ischemic
chest pain for greater than 30 minutes but less than
6 hours, and
○ 18 years of age or older
○ Experiencing chest pain that fails to resolve with
nitrates given as per protocol
Exclusion Criteria
○ Age < 18 years of age
Setting
This study is set in regions of Ontario with a population of
3,043,853 served by 14 EMS services, under the medical
control of 4 regional Base Hospital programs (Table 1)
[27]. These regions represent 25% of the population of
Ontario and 9.6% of the population of Canada. This
geographic region covers 206,727 km
2 with variable
Table 1 List of regional base hospital programs and
emergency medical services participating in PREDICT
study
Regional Basehospital
Programs
Participating Emergency Medical
Services (EMS)
Hamilton Health Sciences
Centre for Paramedic
Education & Research -
Hamilton
County of Brant Ambulance Service
Haldimand EMS
Hamilton EMS
Hamilton-Wentworth Regional
Ambulance Service
Norfolk EMS
Six Nations Ambulance Service
North-East Ontario Regional
Base Hospital Program -
Sudbury
Algoma EMS
Manitoulin-Sudbury EMS
Sudbury EMS
Sault Ste. Marie EMS
Timmins EMS
Northwest Region Base Hospital
Program
Superior North EMS
Sunnybrook Osler Centre for
Prehospital Care - Toronto
County of Simcoe Paramedic Services,
Peel Regional Paramedic Services
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2
representing rural, suburban, urban, and metropolis areas
[27].
Sample Size Calculation
The recruitment goal is to enrol 100 STEMI prospective
subjects per group (e.g. as in the WEST trial)[28], for a
total of 400 STEMI subjects. The primary estimate is
based on a difference in the proportion of patients who
received reperfusion (fibrinolysis or PCI) within target
door-to-intervention times. We based our calculation
using estimates from Canto et al., 2002[29]. In that
study there was an increase in the percentage of the
patients who received lytic therapy within 30 minutes,
from 31% to 50% (an absolute difference of 19%). The
percentage of patients who received PCI within 90 min-
utes increased from 29% to 48% (an absolute difference
of 19%). Furthermore there was a combined 24% higher
odds of receiving fibrinolytic therapy or PCI with the
active EMS involvement (odds ratio 1.24, 95% CI 1.21 to
1.28, p < 0.001). Calculations were conducted using
PASS software, assuming an alpha (a)o f0 . 0 5a n d
power of 80% (Table 2).
To estimate the number of potential subjects that
could be enrolled in the study, the annual rate of STE-
MIs that would occur within a 60 minute transport time
of the closest PCI centre was determined. The sur-
rounding areas within 60 minutes of a PCI centre were
first identified using data from a Cardiac Care Network
of Ontario (CCN) report published in 2004[6]. Current
population estimates were then assigned to each of the
surrounding areas using population estimates for 2006
[27]. For counties or regions where a proportion of the
population resided outside a 60 minute radius, popula-
tion data from the 2006 Canadian census was used from
the census subdivisions to adjust the 2006 population
estimates[27]. To determine the rate of STEMI, an esti-
mate of 571 per 1,000,000 inhabitants was calculated by
taking an estimate obtained using CIHI data of 6524
STEMIs in Ontario for fiscal 2001/02 and dividing it by
the 2006 Ontario Census Population and determining
the rate per million inhabitants[6,27]. The number of
potential subjects to be entered in per year was then
estimated by assuming a 50% transport by EMS rate and
a potential recruitment rate of 70%.
Study Outcomes
Primary Outcome
The primary outcome of this study is to compare the
proportion of study subjects who receive reperfusion
within the target door-to-reperfusion times across the
four care strategies. Target door to reperfusion times
are 90 minutes for primary PCI intervention (door-to-
balloon time) and 30 minutes for fibrinolysis (door-to-
needle time)[30-32].
Secondary Outcomes
Survival
Survival at 30 days and one year after episode date (brief
telephone assessment) for STEMI patients
Treatment Time Intervals
￿ Prehospital scene time interval defined as time from
arrival at scene to departure from scene;
￿ Transport time interval defined as time from depar-
ture from scene to arrival at destination hospital;
￿ Symptom onset time interval defined as time from
symptom onset reported by subject to reperfusion inter-
vention (defined as time to drug administration or bal-
loon inflation);
￿ Primary hospital reperfusion time interval defined as
the time from arrival at primary destination hospital to
reperfusion intervention at the primary destination
(defined as time to drug administration or balloon
inflation);
￿ PCI transfer reperfusion time interval defined as the
time from arrival at primary destination hospital and
transport to a PCI capable site to the reperfusion inter-
vention at the PCI site (defined as time to drug adminis-
tration or balloon inflation).
￿ PCI site reperfusion time interval defined as the time
from arrival at PCI site to reperfusion intervention at
the PCI site (defined as time to drug administration or
balloon inflation)
STEMI Identification with 12-Lead PHECG
￿ Proportion of STEMI subjects within the target door-
to-reperfusion times comparing basic vs. advanced life
support paramedics.
￿ Paramedics and computer software interpretation of
the 3-lead and 12-lead PHECG of all STEMI subjects
will be compared with a gold standard (defined as con-
sensus between two investigators’ independent interpre-
tation blinded to paramedic or software interpretation)
Access to Interventions
The rate of reperfusion strategy utilization across groups
including fibrinolysis, percutaneous coronary angiography
and intervention, coronary artery bypass surgery, bypass to
PCI centre directly vs. transfer from a non PCI centre.
Table 2 Sample size calculation for the PREDICT study
Baseline % Intervention % Absolute
Difference
Odds Ratio Number per
arm
37.4 47.4 10% 1.5 402
37.4 52.4 15% 1.8 185
37.4 57.4 20% 2.3 106
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￿ The direct costs of the 12 lead PHECG program
will be estimated.
￿ Impact on life expectancy gains through reductions
in mortality based on the age and gender of subjects
[33-35];
￿ Cost savings with survival benefits for the domi-
nant treatment strategy or cost and outcome trade-
offs if one treatment strategy demonstrates cost
increasing with survival benefits
￿ Incremental cost-effectiveness, as measured
through additional cost per reduction in door-to-
reperfusion time and additional cost per life year
gained, will be calculated [36,37].
Patients Enrolment
A single trained data guardian/abstractor at each base
hospital will screen all ambulance call reports and iden-
tify all eligible cases. Trained inhospital data abstractors
will be notified to conduct a chart review at each receiv-
ing hospital.
Data Management
All prehospital and inhospital data will be abstracted by
trained staff and entered on a web based interface
employing a structured data set (Additional file 1 -
Prehospital Data Variables and Additional file 2 - Inhos-
pital Data Variables) that complies with institutional,
privacy and ethical requirements. A manual of opera-
tions defines the data name, definition and abstraction
instruction for each variable. Error and logic checks
were built into the database to screen for abnormal
values across forms and within forms at point of entry.
Analysis Plan
The primary outcome, and treatment time intervals, will
be analyzed with one-way ANOVA and subsequent
pair-wise multiple comparison procedures across the
four treatment strategies. Different covariates (Table 3)
will be analyzed using multiple linear regressions and
they will be introduced into the model and evaluated as
potential confounders. Variables will be retained if they
have had an effect of 5% or greater on the coefficients
for door-to-reperfusion time. Survival at 30 days and
one year for STEMI patients will be analyzed as a binary
outcome (Chi square) and as a survival analysis. Covari-
ates that may affect survival will be analyzed with a Cox
PH Regression Model. Adverse event rates will be ana-
lyzed with a Chi square analysis or a Fisher’s exact test.
Economic outcomes will be analyzed using decision
analysis supplemented with probabilistic sensitivity
analysis in a simulation model. Direct costs will be
estimated for each of the four treatment strategies.
Door-to-reperfusion times and mortality will be avail-
able at the patient level, which will allow for the calcula-
tion of averages as well as variability estimates for
analysis of uncertainty. Average cost and effectiveness
(time-to-reperfusion interval and life years) will be cal-
culated and if one treatment strategy is found to be
superior (i.e. cost savings with survival benefits), and
then these results will be reported in a cost consequence
format. If the superior strategy is found to involve cost
and outcome trade-offs (i.e. cost increasing with survival
benefits), then incremental cost-effectiveness, as mea-
sured through additional cost per reduction in time-to-
reperfusion interval and additional cost per life year
gained, will be calculated.
A Priori Subgroup Analysis
￿ Rural vs. urban settings and academic vs non aca-
demic destination hospitals
￿ Geographical bias subgroup analysis comparing all
non PCI capable sites for distance from PCI site;
Ethical Considerations and Human Subjects Protection
PREDICT is an observational, prospective non-interven-
tional study based on review of routinely collected
source data and as such meets the requirements for
minimal risk research[38-40]. Approval by 47 research
ethics boards/committees covering 71 hospitals will be
sought to launch the study.
Discussion
There is a lack of a comprehensive dataset for Acute
Coronary Syndrome (ACS) patients, which includes the
prehospital component of care[3]. We anticipate that
Table 3 Analysis Plan - List of Covariates
1. Presence of cardiac catheterization lab in the primary destination
hospital with the ability to perform 24-7 emergent primary angioplasty;
2. Fully affiliated teaching hospital;
3. Is the ED on Time Consideration (TC) or deferral from ambulances
based on workload of acutely ill or injured patients?
4. Is the ED on Consideration (C) or deferral from ambulances based on
workload?
5. Weekday;
6. Weekend;
7. Time of day in 8 hour intervals (08:00-16:00, 16:00-24:00, 24:00-08:00);
8. Age (as a continuous variable);
9. Sex;
10. History of MI;
11. History of CABG;
12. History of angioplasty;
13. Location of STEMI (anterior, posterior, inferior);
14. Off load delay (minutes);
15. PCA or PCI or bypass surgery.
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mation on processes of care and the benefits of different
prehospital treatment strat e g i e s .W eh a v ep l a n n e dt o
address four threats to protocol compliance and internal
validity; 1) ethics approval and privacy requirements
from 47 research ethics boards/committees covering 71
hospitals, 2) temporal bias of comparison induced by
delays to implementation across sites, 3) data guardian
training and oversight of timeliness and quality, and
4) technological advances that may outpace the study
and affect recruitment.
This trial involves rural and urban centres and this
means that many research ethics boards will need to
review this protocol and our request for waiver of con-
sent. We anticipate that rural and small community hos-
pitals will struggle with the request for waiver of
consent and the privacy issues associated with chart
abstraction, acquisition of personal information enabling
telephone follow up at 30 days and at one year. Our
strategy will be to obtain approval from all the academic
centres first and enclose a copy of their approval with
submission to the smaller centres. In addition we have
established a data sharing agreement template that has
the approval of the administration and legal advisors of
the 18 academic and community hospitals in our largest
metropolitan area. This agreement has been used suc-
cessfully in other trials and we hope this will facilitate
reaching agreement more quickly with hospitals that
have not been involved with research previously. And,
finally our investigators will be on call to the research
ethics board to participate in the discussion at the time
of review. Many small hospital boards request this level
of participation by the investigator. We have found in
the past that this strategy is helpful in minimizing corre-
spondence back and forth between the research team
and the ethics board and reduces time to approval.
We recognize the limitations and challenges that
might affect the study’s successful implementation and
generalizability such as time and spatial challenges. If at
all possible, the study should be launched in all centres
at the same time. However prior to launching, each
PREDICT participating site will need to confer with sta-
keholders to ensure capture of all cases, procurement of
all source documents, optimization of timely data flow,
and training of data abstractors. For some centres this
preparation and initiation phase will be more elaborative
and time consuming then for the others based on
volume and existing infrastructure and prior research
experience. To address these potential delays we will
target the sites we anticipate the REB will be slower to
approve the protocol, with follow up calls and offers to
complete additional information or speak by teleconfer-
ence to the board or to the ethics board chair to facili-
tate understanding and a time l yr e s p o n s et oq u e r i e s .
We will engage the medical directors in all the sites to
ensure the flow of documentation allows for timely data
entry and to encourage them to identify and support a
high quality data guardian for their site. This engage-
ment will take the form of web based reports of site
performance and patient outcomes available 24-7 that
enable medical directors to see their data and compare
to the aggregate site data. To date most medical direc-
tors do not have access to performance or outcome data
and we hope providing this accessibility will speed
implementation and timely quality data. We anticipate
these interventions may be sufficient to allow all sites to
participate concurrently and limit the bias related to
temporal changes in practices during the trial.
By protocol, the data is collected by trained data guar-
dians in all the sites and since almost all the data guar-
dians are geographically remote from the central
research coordinating centre the quality of data may suf-
fer and poise a threat to internal validity. In total there
are 10 data guardians abstracting prehospital data and
16 data guardians abstracting inhospital data. To encou-
rage uniformity in data collection and to provide over-
sight and ensure quality, a number of interventions are
planned. All data guardians will be individually trained
by one of the investigators (VR). The web based data
entry system has built in data definitions and abstraction
instructions which are accessible through point and
click technology on the variable name at the time of
data entry. The abstraction instructions are listed hier-
archically ensuring that the data is abstracted from the
best source if at all possible. All variables are subject to
error and logic checks across other variables and across
forms (inhospital and prehospital) which are applied at
the time of completion and the case will not close with-
out reconciliation of all the error. Web conferences are
conducted for all data guardians to highlight changes to
the data set structure, upgrades to the software and dis-
cuss difficult variables identified by the data guardians
or by the investigators. Data reports to test uniformity
are planned and will be discussed at weekly team meet-
ings of the research staff and investigator steering
meetings.
Technological advances may outpace the study. Some
regions/counties that provide 3-lead ECG in the prehos-
pital setting are not currently considering the change in
technology, while other areas are in the planning or
transitional stages. Any change from 3-lead to 12-lead
in a participating site will compromise recruitment rates
and regional comparisons. If this happens an additional
3-lead site with similar geographic and demographic
characteristics will be recruited and retrospective data
collection will occur to permit concurrent comparisons.
In anticipation of this threat to the protocol we have
engaged each of the EMS medical directors in the
Morrison et al. BMC Emergency Medicine 2011, 11:4
http://www.biomedcentral.com/1471-227X/11/4
Page 5 of 7decision to participate. The window of the trial has been
confirmed to correspond to the planned changes in the
services considering a change.
We have planned a prospective cohort study to compare
outcomes across two different prehospital interventions
(12-lead and 3-lead) and two system changes (transfer to
closest hospital versus bypass closest hospital to transfer
directly to a PCI capable hospital) that do not lend them-
selves to evaluation by a randomized controlled trial. We
anticipate there will be challenges related to ethical and
privacy, oversight of data guardian abstraction, timeliness
of implementation, and technological advances. We hope
that this evaluation may be helpful to those involved in
developing and enhancing multidisciplinary systems of
care including EMS services to advance local care of
patients with STEMI and to inform policy decision making
and evidence based budgetary decisions that ultimately
will affect care across the Province.
Additional material
Additional file 1: PREDICT Prehospital Variables - Structured data
set with variables abstracted from Ambulance Call Reports (ACRs).
Additional file 2: PREDICT Hospital Variables - Structured data set
with variables abstracted from hospital charts.
List of abbreviations
ECG: Electrocardiogram; PHECG: Prehospital electrocardiogram; STEMI: ST
segment elevated myocardial infarction; EMS: Emergency Medical Services;
PCI: Percutaneous coronary intervention; ED: Emergency Department; AMI:
Acute myocardial infarction
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